2m 2m 2m 2m 2m 2m 2m
ANNEXON (ANNX)
NASDAQ
$4.27+$0.05 (+1.31%)
Price as of Nov 11, 2026 6:55 PM EST- $798.1MMarket Cap
- 41.75%1-Year Change
- BiotechnologyIndustry
ANNEXON (ANNX)
$4.27+$0.05 (+1.31%)
ANNX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.21 | ||
Change | -$0.02 (-0.47%) | ||
Open | $4.30 | ||
High | $4.37 | ||
Low | $4.11 | ||
Previous Close | $4.23 | ||
Volume | 4,596,588 | ||
30-Day Average Volume | 3,743,082 | ||
1-Week Change | 0.48% | ||
1-Month Change | 4.73% | ||
1-Year Change | 41.75% | ||
3-Year Change | 98.12% | ||
5-Year Change | -74.70% | ||
Fundamentals | |||
Shares Outstanding | 189.6M | ||
Total Assets | $250.4M | ||
Market Cap | $798.1M | ||
Enterprise Value | $745.1M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$51.2M | ||
Free Cash Flow | -$48.7M | ||
EBIT | -$51.2M | ||
EBITDA | -$50.7M | ||
Net Working Capital | $180.2M | ||
EPS | -$0.25 | ||
Enterprise Value/EBITDA | -15 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 6 | ||
P/E | -17 | ||
PEG | -2 | ||
Price/Free Cash Flow | -16 | ||
Price/Operating Cash Flow | -16 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue